EMA-2023-0022-V422
Major variation for application EMA-2023-0022. Major variation: Formulation Change for Verasenib — critical change
Variation Number
EMA-2023-0022-V422
Type
Major
Application
Change
Status
Pending
Fee
€73,325
Submitted
2023-09-11
Approved
—
Description
Major variation: Formulation Change for Verasenib — critical change